EVALUATION ON THE SAFETY OF TICAGRELOR AMONG INDIAN ACUTE CORONARY SYNDROME (ACS) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION

Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 38

Abstract

BACKGROUND Ticagrelor is the novel class of anti-platelet drugs, has a simpler and faster metabolism (rapid onset of action), high potency and most importantly reversibility. The latter makes this drug safer in patients with bleeding complications. With this background, we studied the safety and tolerability of ticagrelor in Indian patients with acute coronary syndrome undergoing PCI. Primary Objective was to find out the assessment of bleeding events (major, minor or minimal) in acute coronary syndrome patients on Ticagrelor undergoing PCI. Secondary objective was to assess the incidence of dyspnea and other adverse events during 6- months follow up. MATERIALS AND METHODS This was single center, prospective, observational study involving 200 patients hospitalized in Medanta, The Medicity, Hospital, Gurgaon because of ACS undergoing PCI and were treated with Ticagrelor (180mg loading dose and 90mg thereafter) between December 2015 to May 2016. Study Design: Prospective Observational Study. RESULTS Total bleeding was observed in 29 (14.5%) patients, in which major bleeding was seen in 08 (4%) patients, minor bleeding was seen in 07 (3.5%) patients, minimal bleeding was observed in 13 (6.5%) patients, and fatal bleeding was seen in 01 (0.5%) patient Upper Gastro-Intestinal Bleeding (UGIB) was most commonly seen, followed by ecchymosis, lower gastrointestinal bleeding, haematuria, nasal bleeding, haemoptysis and intracranial haemorrhage. Dyspnea was observed in 39 (19.5%) patients among whom only 02 (1%) required discontinuation of study drug. CONCLUSION Study showed that Ticagrelor is a safe newer antiplatelet drug. Since chance of bleeding was significantly higher in females and diabetics, care should be taken in these patients with high risk for bleeding. Also, incidence of major bleeding and myocardial infarction was seen significantly less in our patients as compared to western counter parts. As our study was small observational study, these conclusions need to be confirmed with larger randomized trials in Indian patients.

Authors and Affiliations

Nabi Maknoo G. H. , Mayank Jain, Himanshu Dabral, Rajneesh Kapoor

Keywords

Related Articles

OCULAR MANIFESTATIONS AND SAFETY AWARENESS AMONG QUARRY WORKERS IN PUDUCHERRY

BACKGROUND The study aims to determine the prevalence of ocular manifestations in quarry workers in Puducherry. Quarry workers are at high risk of developing pterygium, dry eye, ocular injuries, scleral pigmentation, non...

A PROSPECTIVE STUDY OF THE COURSE AND OUTCOME OF NUCHAL CORD IDENTIFIED AT 34 WEEKS OF GESTATION

USS report at 34 weeks of gestation may mention presence of nuchal cord. This may cause anxiety and apprehension in the patient. After a detailed counseling, the scan is repeated at 39 weeks to identify those with persis...

STUDY OF ENTEROCUTANEOUS FISTULA

BACKGROUND: A fistula is defined as abnormal communication between two epithelial surfaces. 1 Enterocutaneous fistula is defined as abnormal communication between hollow organ and skin. They are classified as congenital...

INCIDENCE AND SEXUAL PREPONDERANCE OF CONGENITAL MALFORMATIONS IN NICU, AT RIMS, RAICHUR

This is a prospective study of congenital anomalies in babies admitted to NICU at RIMS teaching hospital from September 2014 to March 2015 and half yearly incidence was noted. The anomalies were classified into gastroint...

CARRYING ANGLE: A MORPHOMETRIC STUDY IN SOUTH INDIAN POPULATION

Apes and humans are distinguished from other primate species in possessing carrying angle at the elbow. When the upper extremity is in the anatomic position, the long axis of the humerus and the long axis of the ulna for...

Download PDF file
  • EP ID EP572268
  • DOI 10.18410/jebmh/2018/561
  • Views 104
  • Downloads 0

How To Cite

Nabi Maknoo G. H. , Mayank Jain, Himanshu Dabral, Rajneesh Kapoor (2018). EVALUATION ON THE SAFETY OF TICAGRELOR AMONG INDIAN ACUTE CORONARY SYNDROME (ACS) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. Journal of Evidence Based Medicine and Healthcare, 5(38), 2735-2741. https://europub.co.uk/articles/-A-572268